Novavax CEO on Sanofi deal: 'This is a new chapter in the history of our company'

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 46 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 36%
  • Publisher: 63%

John Jacobs 뉴스

Sanofi,Biotech Company,Novavax

Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.

The deal gave Novavax a much-needed cash boost, helping it reverse more than a year of declining value.

When asked if Sanofi had previously approached Novavax for partnership, CEO Jacobs said he couldn't comment. Novavax beat on earnings per share, at $1.08 versus consensus estimates of $1.05, but it missed on revenues, reporting $98.3 million compared to Wall Street expectations of more than $101 million.is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics.

Warren Buffett teased a potential Canada bet, predicted Berkshire would surpass $200 billion in cash this quarter, and shrugged off dollar worries.TD Bank stock looks like a great bargain after its latest plunge over the ongoing U.S. probe. The post TD Bank Stock Falls 6% on Money-Laundering Investigation: Deal or Danger? appeared first on The Motley Fool Canada.BCE Inc stock has a high yield but persistently negative earnings growth.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 47. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인